Cart summary

You have no items in your shopping cart.

D-(-)-Penicillamine

SKU: orb1224795

Description

(2S)-2-Amino-3-methyl-3-sulfanylbutanoic acid is the most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Target: Others (2S)-2-Amino-3-methyl-3-sulfanylbutanoic acid (Cuprimine, Depen) is used as an antirheumatic and as a chelating agent in Wilson's disease and is a chelating agent recommended for the removal of excess copper in patients with Wilson's disease. From in vitro studies which indicate that one atom of copper combines with two molecules of penicillamine. \n(In Vitro):Penicillamine (D-(-)-Penicillamine) (5 mg; 7 d; CD4+ and CD+ splenocytes) promotes cellular immune responses.(In Vivo):Penicillamine (D-(-)-Penicillamine) (200 mg/kg; i.g.; daily, for 3, 10 and 14 d; tx mice and DL mice) increases serum free copper concentration.Penicillamine (200 mg/kg; i.g.; daily, for 3, 10 and 14 d; tx mice and DL mice) increases ATP7A and CTR1 mRNA expression in the brain of tx mice.Penicillamine (200 mg/kg; i.g.; daily, for 3, 10 and 14 d; tx mice and DL mice) induces oxidative-stress in the central nervous system.Penicillamine (0.1-250 mg/kg; i.p.; once, for 90 min; male NMRI mice) has binaural phase effect on seizure.Penicillamine (5 mg/kg; i.v.; daily, for 8 weeks; male BN rats) prevents the onset of autoimmunity at a low dose.

Images & Validation

Key Properties

CAS Number52-67-5
MW149.21
Purity>98% (HPLC)
FormulaC5H11NO2S
SMILESCC(C)([C@H](C(=O)O)N)S
TargetCopper
SolubilityWater: 30 mg/mL (201.05 mM)

Bioactivity

In Vivo
Penicillamine (D-(-)-Penicillamine) (200 mg/kg; i. g. ; daily, for 3, 10 and 14 d; tx mice and DL mice) increases serum free copper concentration. Penicillamine (200 mg/kg; i. g. ; daily, for 3, 10 and 14 d; tx mice and DL mice) increases ATP7A and CTR1 mRNA expression in the brain of tx mice. Penicillamine (200 mg/kg; i. g. ; daily, for 3, 10 and 14 d; tx mice and DL mice) induces oxidative-stress in the central nervous system. Penicillamine (0.1-250 mg/kg; i.p.; once, for 90 min; male NMRI mice) has binaural phase effect on seizure. Penicillamine (5 mg/kg; i. v. ; daily, for 8 weeks; male BN rats) prevents the onset of autoimmunity at a low dose. Animal model: Toxic milk mutant mice (tx mice) and DL mice. Dosage: 200 mg/kg. Administration: Oral gavage; daily, for 3, 10 and 14 days. Result: Increased the free copper concentrations in the tx mice serum on the 3rd day. Animal model: Toxic milk mutant mice (tx mice) and DL mice. Dosage: 200 mg/kg. Administration: Oral gavage; daily, for 3, 10 and 14 days. Result: Increased the mRNA expression of ATP7A by 4-fold. Increased CTR1 mRNA expression by 6.9-fold in the cortex and 9.1-fold in the basal ganglia of tx mice. Animal model: Toxic milk mutant mice (tx mice) and DL mice. Dosage: 200 mg/kg. Administration: Oral gavage; daily, for 3, 10 and 14 days. Result: Increased the concentration of MDA and decreased GSH/GSSG ratios through nitric oxide/NMDA pathways. Animal model: Male NMRI mice. Dosage: 0.1, 0.5, 1, 10, 100, 150 and 250 mg/kg. Administration: Intraperitoneal injection; once, for 90 minutes. Result: Had anticonvulsant effects at a low dose (0.5 mg/kg) and had anticonvulsant effects at a high dose (250 mg/kg). Reversed the anti-and proconvulsant effects by acute pretreatment of L-NAME (a nonselective nitric oxide synthase inhibitor) and 7-NI (a selective neuronal nitric oxide synthase inhibitor). Animal model: Male BN rats. Dosage: 5 mg/kg. Administration: Intravenous injection; daily, for 8 weeks. Result: Inhibited IgE upregulation and prevented the onset of autoimmunity.
In Vitro
Penicillamine (D-(-)-Penicillamine) (5 mg; 7 d; CD4+ and CD+ splenocytes) promotes cellular immune responses. Western blot analysis. Cell line: CD4+ and CD+ splenocytes. Concentration: 5 mg. Incubation time: 7 days. Result: Increased IL-4 and IFN-γ mRNA expression in response to high dose treatment and remained high in both CD4+ and CD+ splenocytes.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

NSC 81549 | D-Penicillamine | β-Thiovaline

Similar Products

  • Penicillamine [orb1310105]

    99.92%

    52-67-5

    149.21

    C5H11NO2S

    5 g
  • D-Penicillamine disulfide [orb3021565]

    20902-45-8

    296.41

    C10H20N2O4S2

    10 mg, 50 mg
  • N-Acetyl-D-penicillamine [orb3054062]

    >98% (HPLC)

    15537-71-0

    191.25

    C7H13NO3S

    10 mg, 100 mg, 50 mg, 25 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

D-(-)-Penicillamine (orb1224795)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
200 mg
500 mg
10 mg
$ 100.00
25 mg
$ 140.00
50 mg
$ 160.00